About
Lonza Group Ag (SW:LONN) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 21 2026
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Mar 6 2026
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG
Jan 7 2026
Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific ADCs
Sep 25 2025
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC
Recent Videos

Жіночі білі базові кеди Allse Lonza 206754 23276 White-Beige 6158, шкіряні на платформі у N-SHOES
Apr 22, 2026

3 companies we partner with in biotechnology
Apr 14, 2026

Twin Lonza pens #ceramic
Apr 14, 2026

Scalable Biologics Production Trends: Featuring Omar Wahab of Lonza
Apr 10, 2026
Financials
Revenue
CHF6.53 B
Market Cap
CHF35.93 B
P/E Ratio
39.37
EPS
13.01
Dividend Yield
0.97%
Google Übersetzer